...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 6%
6%
2
Dec 14, 2022 02:52PM
3
Dec 14, 2022 03:46PM

No takers?  No one knows what the 6% is?

In the AGM presentation, on slide 14, bottom right, under Zenith Epigenetics Ltd., it says

----> "6% Royalty to be paid to Zenith Capital Corp."

What is that?   I can't find it in the SEDAR docs. 

3
Dec 15, 2022 10:27AM

Dec 15, 2022 10:39AM
2
Dec 15, 2022 10:55AM
2
Dec 15, 2022 11:10AM
1
Dec 15, 2022 11:21AM
1
Dec 15, 2022 11:28AM
1
Dec 15, 2022 11:29AM
1
Dec 15, 2022 11:36AM
Share
New Message
Please login to post a reply